CHESTER, N.J., Aug. 20 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. today announced that it has been named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Rankings are based on companies' percentage revenue growth over the five year period from 2002 to 2006. Deloitte & Touche USA LLP, is one of the nation's leading professional services organizations.
Adams Respiratory Therapeutics' CEO Michael J. Valentino said, "I am extremely pleased that Adams was ranked seventh overall, out of the companies honored in Deloitte's Technology Fast 50 program. We are very proud to be recognized by Deloitte for achieving a revenue growth rate of 1,638 percent from 2002 to 2006."
Valentino added, "It has been exhilarating to see the things we've done take hold. Our unique regulatory strategy for Mucinex(R) coupled with our synergistic blend of consumer and professional marketing for the Mucinex brand helped fuel our phenomenal growth over the past five years. Mucinex was approved and launched in July 2002, and since then we have been able to successfully execute against our strategy to diversify and expand our product portfolio. We now market nine over-the-counter products with multiple new product introductions planned this fall. Additionally, we also plan to expand into the prescription respiratory market as early as 2008. Deloitte's recognition of our success is something that makes all of us at Adams very proud."
Companies from the 16 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.CONTACT: Janet M. Barth, +1-908-879-2428, for Adams RespiratoryTherapeutics, Inc.
